Mahdi Shahriari
Overview
Explore the profile of Mahdi Shahriari including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bordbar S, Shahriari M, Zekavat O, Mottaghipisheh H, Haghpanah S, Bordbar M
BMC Cancer
. 2024 Nov;
24(1):1388.
PMID: 39533245
Background: Wilms tumor (WT) is the most common malignant renal tumor in children. This study investigated the clinical features, pathological findings, and outcomes of children with malignant renal tumors in...
2.
Bordbar M, Vahidifar M, Zarshenas M, Haghpanah S, Zareifar S, Shahriari M, et al.
Am J Blood Res
. 2023 Nov;
13(5):143-151.
PMID: 38023416
Introduction: Febrile neutropenia is a serious complication of cancer chemotherapy that can result in delays in treatment. This study evaluates the efficacy of L. at neutrophil recovery time in children...
3.
Rahimi K, Amoozgar H, Zareifar S, Shahriari M, Zekavat O, Karimi M, et al.
Egypt Heart J
. 2023 Mar;
75(1):21.
PMID: 36961611
Background: Cardiotoxicity is a major concern following doxorubicin (DOX) use in the treatment of malignancies. We aimed to investigate whether deferoxamine (DFO) can prevent acute cardiotoxicity in children with cancer...
4.
Amanati A, Shahriari M, Bordbar M, Hedayati S, Ziyaeyan M, Jamalidoust M, et al.
J Med Case Rep
. 2023 Feb;
17(1):66.
PMID: 36765433
Background: Like other viral infections, severe acute respiratory syndrome coronavirus-2 infection could affect different human body systems, including host immune responses. Three years after its pandemic, we learn more about...
5.
Bordbar M, Jam N, Karimi M, Shahriari M, Zareifar S, Zekavat O, et al.
Cancer Rep (Hoboken)
. 2023 Jan;
6(4):e1784.
PMID: 36700480
Background: The survival of childhood leukemia has improved. We aimed to report the survival rate and the associated factors in children with acute leukemia during an 8-year follow-up. Aims: This...
6.
Zekavat O, Safari A, Bordbar M, Haghpanah S, Zareifar S, Shahriari M, et al.
Clin Lab
. 2022 Feb;
68(2).
PMID: 35142188
Background: Asparaginase (ASP), a chemotherapy component in the acute lymphoblastic leukemia (ALL) treatment, could impair normal coagulation state. Usually, a decline in the levels of several coagulation factors occurs which...
7.
Nemati H, Boroujeni A, Inaloo S, Katibeh P, Shahriari M
Neurol India
. 2021 Nov;
69(5):1343-1348.
PMID: 34747809
Background And Objectives: Folate is an important vitamin with a significant role in cell metabolism processes, and its deficiency is associated with several diseases. In addition, cerebral folate deficiency is...
8.
Daneshfard B, Shahriari M, Nimrouzi M
Galen Med J
. 2021 Sep;
8:e1600.
PMID: 34466535
No abstract available.
9.
Mottaghipisheh H, Kalantar K, Amanati A, Shokripour M, Shahriari M, Zekavat O, et al.
BMC Infect Dis
. 2021 Aug;
21(1):732.
PMID: 34340686
Background: Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of excessive inflammation. We aimed to describe the clinical and laboratory findings of HLH patients secondary to Visceral leishmaniasis (VL) and their treatment...
10.
Shahriari M, Dehghankhalili S, Heiran A, Daneshfard B
Iran J Public Health
. 2021 Jun;
50(5):1077-1078.
PMID: 34183970
No abstract available.